Boston Scientific launches Interlock

Thursday, June 30, 2011 01:25 PM

Boston Scientific has launched its Interlock-35 Fibered IDC Occlusion System in the U.S. and Europe.  Earlier this year, the system received clearance from the FDA and CE Mark approval for obstructing or reducing blood flow in the peripheral vasculature during embolization procedures.

The Interlock-35 System consists of a 0.035" detachable coil with an interlocking connection between the coil and delivery wire designed to offer placement control, including the ability to advance, retract and reposition the coil before final deployment in the vessel.  The coil is engineered to be detached by simply pushing the detachment zone beyond the distal end of the 5F delivery catheter.  The platinum coil is constructed with a network of synthetic fibers, designed to offer thrombogenicity (blockage of blood flow) and rapid stasis.

The Interlock-35 Fibered IDC Occlusion System is available in 31 configurations that include coil lengths from 4cm to 40cm, diameters from 3mm to 20mm, and three distinct shapes (cube, 2D helical and diamond) to offer physicians greater flexibility to treat diverse vessel anatomy.  When combined with Boston Scientific's 0.018" Interlock Fibered IDC Coils, the Interlock Coil portfolio provides 50 different coils to optimize peripheral embolization procedures.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs